Biomarx specializes in automated genomic diagnostics.
Biomarx has raised $941K in total funding. The most recent round was Pre-Seed. The last funding was announced in January 2026.
Biomarx's investors include SFC Capital, University of Strathclyde, Clarendon Fund Managers, InterTradeIreland Seedcorn Investor Readiness Competition, Techstart.
Biomarx is headquartered in Belfast, United Kingdom.
Biomarx specializes in automated genomic diagnostics.
Biomarx is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biomarx — Funding & Investors." VCBacked, January 5, 2026, https://www.vcbacked.co/company/biomarx. Accessed September 15, 2026.
VCBacked. (2026). Biomarx — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/biomarx
{{cite web |title=Biomarx — Funding & Investors |url=https://www.vcbacked.co/company/biomarx |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated